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A spontaneous point mutation in pilQ (pilQ1) resulted in phenotypic suppression of a hemoglobin (Hb)
receptor mutant (hpuAB mutant), allowing gonococci to grow on Hb as the sole source of iron. PilQ, formerly
designated OMP-MC, is a member of the secretin family of proteins located in the outer membrane and is
required for pilus biogenesis. The pilQ1 mutant also showed decreased piliation and transformation efficiency.
Insertional inactivation of pilQ1 resulted in the loss of the Hb utilization phenotype and decreased entry of free
heme. Despite the ability of the pilQ1 mutant to use Hb for iron acquisition and porphyrin, there was no
demonstrable binding of Hb to the cell surface. The pilQ1 mutant was more sensitive to the toxic effect of free
heme in growth medium and hypersensitive to the detergent Triton X-100 and multiple antibiotics. Double
mutation in pilQ1 and tonB had no effect on these phenotypes, but a double pilQ1 pilT mutant showed a
reduction in Hb-dependent growth and decreased sensitivity to heme and various antimicrobial agents.
Insertional inactivation of wild-type pilQ also resulted in reduced entry of heme, Triton X-100, and some
antibiotics. These results show that PilQ forms a channel that allows entry of heme and certain antimicrobial
compounds and that a gain-of function point mutation in pilQ results in TonB-independent, PilT-dependent
increase of entry.
Mammalian hosts use iron-binding proteins and iron-se-
questering compounds to maintain free iron at a level that is
too low for the growth of invading pathogens. Many patho-
genic bacteria have evolved mechanisms for scavenging essen-
tial iron in vivo from transferrin, lactoferrin, hemoglobin (Hb),
and other sources. The ability to scavenge iron is important to
bacterial growth in vivo and therefore virulence (49). Many
bacteria acquire iron by secretion of iron siderophores, but
pathogenic neisseriae do not produce siderophores, relying
instead on specific receptors for binding host iron compounds,
including transferrin, lactoferrin, and Hb (12, 35). Either the
transferrin or the lactoferrin receptor is essential for gonococci
to cause urethral infection in male volunteers (1, 11). More-
over, the presence of both the transferrin and lactoferrin re-
ceptors provides a selective advantage during experimental
male urethral infection (1, 11). The phase-variable gonococcal
HpuAB Hb receptor apparently is not involved in infection of
the male urethra but is selected in vivo in women during the
first half of the menstrual cycle (2) and therefore also is im-
portant to infection.
Mechanisms of iron uptake from Hb by the pathogenic neis-
seriae are well studied (5, 6, 7, 21, 22, 23, 24, 41, 42), but many
details remain unclear. Meningococci express two Hb recep-
tors: HmbR for binding Hb or HpuAB for binding either Hb
alone or Hb bound to its serum binding protein haptoglobin
(22). Gonococci express only the HpuAB receptor, although
they do possess an hmbR pseudogene (42). HpuA is a lipopro-
tein, and HpuB is an integral outer membrane protein. Both
HpuA and -B are essential for use of Hb as an iron source (5).
Construction of hemA mutants that cannot synthesize heme
proved that gonococci which express HpuAB can utilize Hb-
bound heme as a source of porphyrins, and thus heme enters
the cytoplasm intact (48). The function of the HpuAB receptor
is dependent on activation by TonB (3). HpuA facilitates bind-
ing of Hb to the receptor and protects free heme released on
the outer surface of the bacterium from binding by human
serum albumin (HSA) (6). Heme released from Hb bound to
the HpuAB receptor apparently traverses a pore within HpuB
in a TonB-dependent manner (6) and then crosses the
periplasmic space and cytoplasmic membrane by unknown
mechanisms.
Gonococci and meningococci also can utilize free heme for
growth in the absence of an Hb receptor (16, 44). Gonococcal
growth with free heme does not require TonB (3, 7, 44, 48)
and, although the existence of a heme receptor has been sug-
gested (19, 20), one has never been clearly identified in either
meningococci or gonococci. At present, pathways for entry and
transport of free heme in the absence of an Hb receptor are
not well understood.
Recently, we utilized an hpuA deletion mutant of gonococcal
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strain FA1090 to isolate two classes of Hb-utilizing (Hb)
mutants. One class required TonB and had point mutations in
hpuB that restored entry of heme from Hb in the absence of
HpuA, whereas the other required neither TonB nor HpuAB
(6). The HpuAB- and TonB-independent Hb mutants were
designated hgbX, in recognition of the lack of understanding of
the molecular basis for the Hb-utilizing phenotype. The hgbX
mutants exhibited increased sensitivity to certain antimicrobial
agents and grew normally on both Hb and low concentrations
of free heme.
We report here that two of the mutants formerly designated
hgbX are due to a specific point mutation in the pilQ gene
(pilQ1) that allows gonococci to utilize Hb as a source of
essential heme iron and porphyrins in the absence of an Hb
receptor. Formerly designated the major subunit of outer
membrane protein-macromolecular complex (OMP-MC) (18,
47), PilQ is a member of the secretin family of proteins (34),
which functions in type IV pilus organelle biogenesis in Neis-
seria gonorrhoeae (13, 52). The type IV pilus is required for
twitching motility and DNA transformation competence (30,
50), and the pilQ1 point mutation allows for both pilus biogen-
esis and DNA transformation but at slightly reduced levels. We
demonstrate that the pilQ1 point mutation that results in use of
Hb as a heme and iron source in the absence of an Hb receptor
also results in elevated sensitivities to various antimicrobial
compounds. The phenotype is dependent on the expression of
the mutant form of PilQ and in part on expression of PilT.
Thus, this mutant PilQ allows for increased entry of exogenous
compounds into the bacterial cell in addition to its role in pilus
fiber extension.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The parent strain used in this study
was FA1090. Plasmids and gonococcal strains constructed and/or utilized in this
study are listed in Table 1. The growth conditions of gonococcal and Escherichia
coli strains were as described previously (43). Strains unable to utilize Hb as the
sole source of iron (Hb) were grown on Bacto GC medium base (Difco/Becton
Dickinson, Sparks, Md.) plates (GCB plates) containing Kellogg’s Supplement I
plus 12 M ferric nitrate. Strains that were able to grow on Hb (Hb) were
grown on GCB plates or modified GCB plates (Hb-Des plates) containing
human Hb at a concentration of 2 M and desferoxamine mesylate (Desferal) at
100 M instead of ferric nitrate.
Antibiotics in growth media were used at the indicated concentrations unless
otherwise noted: for E. coli strains, ampicillin (AMP) at 100 g/ml, erythromycin
(ERY) at 100 g/ml, chloramphenicol (CHL) at 30 g/ml, kanamycin (KAN) at
30 g/ml; for gonococcal strains: erythromycin at 1 g/ml (ERY1), chloramphen-
icol (CHL) at 1 g/ml (CHL1), spectinomycin (SPT) at 100 g/ml (SPT100), and
tetracycline (TET) at 2 g/ml (TET2). A stock solution of heme was prepared by
dissolving 10 mg of bovine hemin chloride in 1 ml of 0.1 N NaOH. A stock
solution of Hb was prepared by dissolving 100 mg of human Hb in 10 ml of 10
mM HEPES (pH 7.4). The solution was rocked overnight at 4°C and then filtered
through a 0.45-m-pore size Acrodisc (Pall Gelman Laboratory, Ann Arbor,
Mich.).
Reagents, oligonucleotides, and DNA sequencing. All chemicals were pur-
chased from Sigma (St. Louis, Mo.) unless otherwise indicated. Oligonucleotides
were synthesized at the Lineberger Comprehensive Cancer Center DNA Syn-
thesis Facility of the University of North Carolina–Chapel Hill. Sequencing was
carried out at the Automated DNA Sequencing Facility of the University of
North Carolina–Chapel Hill with an Applied Biosystems model 373 DNA se-
quencer by use of the Taq dye terminator cycle sequencing kit (Applied Biosys-
tems/Perkin-Elmer, Foster City, Calif.) or in the Seifert laboratory on a Beckman
Coulter CEQ L system. All oligonucleotides used as primers for PCR or DNA
sequencing of pilQ are listed in Table 2.
Construction of FA7168, FA7186 and mutagenesis of tonB and hemA. Con-
struction of hpuA deletion (hpuA) mutants which express HpuB under the
control of the hpuA promoter and isolation of FA7168, a hpuA hpuB::cat hgbX
mutant that grew on Hb, were described previously (6). Isolation of the Hb
FA7168 from the Hb FA7167 (also hpuA hpuB::cat) prompted us to seek Hb
revertants among derivatives of FA7169 (hpuA hpuB) that were unable to
grow on Hb. A hmbR:: derivative of FA7169 that cannot revert to Hb by point
mutations in the pseudogene, hmbR, was named FA7186. Hb mutants of
FA7186 were identified by plating cell suspensions on Hb-Des plates and picking
colonies that grew well when passed onto fresh Hb-Des plates.
TonB dependence of Hb, hgbX mutants was tested by insertional inactivation
of tonB with the  cassette. This procedure utilized the tonB:: plasmid
pUNCH173 (3) to transform various hpuA mutants with selection for resistance
to SPT. The ability of various mutants to utilize Hb as a heme source was tested
by the construction of hemA mutants utilizing the hemA:: plasmid pUNCH1306
for transformation as described by Turner et al. (48).
Cloning the pilQ1 gene. FA7168 chromosomal DNA fragments of various sizes
were obtained after Sau3AI partial digestion and agarose gel electrophoresis
fractionation (10). Fragments of 0.5 to 4 kb eluted from gel slices were divided
into five fractions and transformed into FA7167. The fraction with DNA frag-
ments of 1.6 to 3 kb was enriched in the gene (see below) that transformed
FA7167 to Hb. A plasmid DNA library of this fraction was prepared by insert-
ing DNA fragments into BamHI-digested, shrimp alkaline phosphatase (Boehr-
inger Mannheim)-treated, pBluescript II KS() (Stratagene, La Jolla, Calif.)
and cloning them in E. coli DH5MCR (Gibco-BRL, Gaithersburg, Md.). Pools
of plasmid DNA were generated and used to individually transform Hb FA7167
to Hb. Active pools were subdivided and screened again until eventually a
single 5.2 kb clone was identified that conferred the ability to utilize Hb. The
2.2-kb gonococcal insert in this clone contained 862 bp of the 3 end of pilQ, and
comparison to the gonococcal genomic database (GenBank accession
NC002946) showed that it contained a point mutation 412 bp from the 3 end of
the open reading frame of pilQ. This allele was designated pilQ1.
Oligonucleotides were designed (Table 2) to amplify and sequence pilQ from
the genomes of hgbX mutants derived from FA7186. The DNA sequences re-
vealed that FA7186H19 had precisely the same pilQ point mutation as that of
FA7168. Of six mutants with the hgbX phenotype, FA7168 carried a cat cassette
in hpuB; the rest were derivatives of FA7186 and carried the  cassette in hmbR.
They were all sensitive to CHL1 despite expression of the cat resistance cassette
in the hpuB of FA7168.
In order to use the  cassette to inactivate pilQ and to provide further proof
that the point mutation in pilQ was responsible for the Hb phenotype,
FA7186H19 pilQ1 was moved by transformation into FA7167 (hpuA hpuB::cat,
Hb), with selection for Hb. A parallel transformation was done with the
chromosomal DNA of FA7168. All Hb transformants from these crosses were
SPT100 and CHL1 sensitive (SPTs CHLs). Genomic PCR and DNA sequencing
confirmed the presence of pilQ1 point mutation in the Hb transformants. The
transformant with chromosomal DNA from FA7168 was named FA7317. Two
transformants obtained from two transformations by FA7186H19 DNA were
named FA7294 and FA7318.
Mutagenesis of pilQ. A shortened version of pilQ was made by genomic-PCR
with the upstream PCR primer hgbX08, which started 434 bp from the ATG site,
and the downstream primer hgbX03, which ends 52 bp after the TGA site. The
1,872-bp PCR product from FA7168 was inserted into the vector PCR2.1-TOPO
(Invitrogen) and cloned in E. coli DH5MCR to generate pUNCH 288. A 30-bp
segment of pUNCH 288 between two HincCII sites was removed and replaced
with a  cassette to become pUNCH 290. Replacing the same segment with a cat
cassette generated pUNCH 291. Both pUNCH 290 and pUNCH291 were used
to create pilQ insertional knockout mutants. Western blots were performed to
confirm loss of PilQ by using a rabbit antiserum against OMP-MC kindly sup-
plied by Charles E. Wilde III (Indiana University School of Medicine).
Construction of gonococcal pilQ mutants in RM11.2recA6 background. The
FA1090 derivative RM11.2recA6 (25, 31) was induced with isopropyl--D-thio-
galactopyranoside (IPTG) and transformed with FA7167 chromosomal DNA,
which contains the hpuA hpuB::cat mutations. CHL1-resistant (CHLr) trans-
formants were screened by Southern blot hybridization and PCR analysis, and
the pilE sequence was determined. The hpuA hpuB::cat mutant of
RM11.2recA6 was named FA7332. FA7332 was transformed with FA7168 chro-
mosomal DNA that contains pilQ1. Transformants with the pilQ1 point mutation
(FA7333) were identified by growth on Hb-Des plates and were authenticated by
genomic PCR and DNA sequencing of pilQ and pilE.
RM11.2recA6 pilE and RM11.2recA6 hpuA hpuB::cat pilE mutants were
generated by induction of recA with IPTG and selection of nonpiliated areas of
growth on colonies. To delete the pilE of FA7333, chromosomal DNA from
RM11.2recA6 pilE was used to transform in the deletion. The pilE deletions
were verified with Southern blot and PCR analysis. DNA sequencing determined
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that the 924-bp deletion spans between upstream sequence and the cys2 se-
quence in pilE, which deletes the pilE promoter and ribosomal binding site.
Construction of pilT mutants. In order to make pilT mutants of strains in the
RM11.2recA6 background, FA7332 and FA7333 were transformed with
RM11.2recA6 pilT::erm (26) chromosomal DNA. ERY1-resistant transformants
of FA7332 and ERY0.05-resistant transformants of FA7333 were screened by
Southern blot analysis. The insertional inactivation of pilT was identified by
screening for the characteristic colony morphology differences of pilT (dud1)
mutants (4). These pilT mutants carried the parental pilE sequence. The
pilT::erm mutants of FA1090, FA7168, FA7186H19, FA7317, and FA7318 were
constructed by moving chromosomal DNA of RM11.2recA6 pilT::erm into the
recipients. Transformants of FA1090 were selected on ERY1, and transformants
of the pilQ1 mutants were selected on ERY0.5 plates. In order to evaluate the
effect of PilT inactivation on ERY sensitivity, FA1090, FA7167, and FA7186H19
were also transformed with chromosomal DNA of an MS11 mutant carrying an
inducible pilT promoter. (The mutation was moved into MS11 by Laura Potter
of Oregon Health Sciences University from a strain originally constructed in the
laboratory of Michael Koomey [50], University of Oslo, Oslo, Norway.) Trans-
formants were selected on TET2. Preservation of the hpuA deletion and hpuB
insertion in these pilT mutants were confirmed by genomic PCR and DNA
sequencing.
TABLE 1. Plasmids and gonococcal strains constructed and/or used in this study
Plasmid or strain Genotype and phenotype Source or reference
Plasmids
pHP45 Source for  (Spr Smr) cassette 32
pNC40 Source for cat (Cmr) cassette 46
pUNCH173 tonB:: 3
pUNCH1306 hemA:: 48
pUNCH288 Partial FA7168 pilQ1 in pCR2.1-TOPO This study
pUNCH290 pilQ1:: of p288 This study
pUNCH291 pilQ1::cat of p288 This study
Strains
FA1090 Parent strain; wild type 15
FA1090 H HpuAB phase on variant of FA1090 7
FA7167 hpuA hpuB::cat; Cmr Hb 6
FA7168 Cms Hb revertant of FA7167; pilQ1 6
FA7169 hpuA hpuB derivative of FA7167; Cms Hb 6
FA7186 hmbR:: transformant of FA7169; Spr Hb 6
FA7186H1 hgbX2; Spr Hb revertant of FA7186 6
FA7186H12 hgbX3; Spr Hb revertant of FA7186 This study
FA7186H15 hgbX4; Spr Hb revertant of FA7186 This study
FA7186H19 Spr Hb revertant of FA7186; pilQ1 This study
FA7186H20 hgbX6; Spr Hb revertant of FA7186 This study
FA7294 FA7186H19 pilQ1 transformant of FA7167; Cms Sps Hb This study
FA7311 pilQ:: transformant of FA1090 H; Spr Hb This study
FA7312 pilQ1:: transformant of FA7294; Spr Hb This study
FA7317 FA7168 pilQ1 transformant of FA7167; Cms Sps Hb This study
FA7318 FA7186H19 pilQ1 transformant of FA7167; Cms Sps Hb This study
FA7319 pilQ:: transformant of FA7167; Spr Hb This study
FA7320 pilQ1:: transformant of FA7317; Spr Hb This study
FA7321 tonB:: transformant of FA7317; Spr Hb This study
FA7322 hemA:: transformant of FA7317; Spr Hb This study
RM11.2recA6 Defined P variant of FA1090 with IPTG-regulated recA 25
FA7332 (RM7167) hpuA hpuB::cat transformant of RM11.2recA6; Hb This study
FA7333 (RM7168) FA7168 pilQ1 transformant of FA7332; Hb This study
FA7334 pilT::erm transformant of RM11.2recA6 26
FA7335 pilQ1 pilT::erm transformant of RM11.2recA6 This study
FA7336 pilE of RM11.2recA6 This study
FA7337 pilE transformant of FA7332 This study
FA7338 pilE transformant of FA7333 This study
FA7339 pilQ1 transformant of RM11.2recA6 This study
FA7340 pilT::erm transformant of FA7333 This study
FA7341 pilT::erm transformant of FA1090 This study
FA7342 pilT::erm transformant t of FA7168 This study
FA7343 pilT::erm transformant of FA7186H19 This study
FA7344 pilT::erm transformant of FA7317 This study
FA7345 pilT::erm transformant of FA7318 This study
FA7348 pilT::tet transformant of FA1090 This study
FA7349 pilT::tet transformant of FA7167 This study
FA7350 pilT::tet transformant of FA7186H19 This study
a Spr, SPT resistance; Smr, streptomycin (100 g/ml) resistance; Cmr, CHL resistance.
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Immunoelectron microscopy. For analysis of gonococcal piliation states,
Formvar-coated grids were used to lift cells directly from 18-h-old colonies grown
on GCB plates. Grids were fixed for 15 min by floating on a drop of 0.2%
glutaraldehyde–4% paraformaldehyde (Fisher Scientific). After fixation, the
grids were rinsed three times with Dulbecco phosphate-buffered saline (PBS;
Gibco-BRL) with 1% bovine serum albumin (BSA; Sigma) and then incubated
in 0.1% gelatin (Aurion, Inc.) in PBS for 30 min. The grids were rinsed once with
PBS-BSA and then incubated with a 1:10 dilution of rabbit -pilin peptide
antiserum (26) for 1 h. The antiserum was raised against a synthetic peptide
found in the hypervariable loop region of the pilin variant expressed on
RM11.2recA6 (KRDAGAKTGADDVKADGN), synthesized on keyhole limpet
hemocyanin resin and used to immunize New Zealand White female rabbits
(Research Genetics). Grids were rinsed three times with PBS-BSA and incu-
bated with 0.1% gelatin in PBS for 30 min. The grids were rinsed once with
PBS-BSA and incubated with goat -rabbit immunoglobulin G antibody conju-
gated to 12-nm gold (1:20 dilution; Jackson Immunolabs) for 1 h. Grids were
rinsed five times in water for 3 min each step. Excess water was carefully wicked
away, and grids were negatively stained with 1% uranyl acetate for 1 min. All
incubations were performed at 25°C. Grids were viewed by using a JEOL JEM-
1220 transmission electron microscope at 60 kV.
Transformation competence assays for strains in RM11.2recA6 background.
Gonococci were grown on GCB plates for 18 h, collected with dacron swabs, and
suspended to a density of 108 CFU/ml in liquid GCB (GCBL). Then, 20 l of
cells was added to 200 l of GCBL that contained 5 mM MgSO4 (35), Kellogg
supplements, 1 mM IPTG, and 50 ng of pSY6 (37). After 15 min at 37°C, DNase
I (Promega) was added, and the incubation was continued for 5 min at 37°C to
remove exogenous DNA. Then, transformation mixes were diluted into 2 ml of
GCBL plus 5 mM MgSO4, Kellogg supplements, and 1 mM IPTG, followed by
incubation at 37°C in 5% CO2 for 4 h without agitation. Transformants were
selected on GCB plates containing 2 g of nalidixic acid (NAL)/ml.
Hb-binding assays. These procedures were as described previously (6). Briefly,
the binding was measured by 125I-labeled anti-human Hb antibodies bound to
buffer-washed whole cells previously incubated in Chelex-treated defined me-
dium (CDM) supplemented with Hb.
Growth and microbial sensitivity assays. The ability of a gonococcal strain to
use Hb or heme for growth was measured in liquid culture with iron-chelated
CDM or on GCB-Des agar plates into which defined amounts of Hb or heme
were placed into wells cut into the agar, as described previously (6). Disk assays
were used to test antimicrobial sensitivities on GCB agar plates. Single, pheno-
typically piliated colonies of strains to be tested were passed from selection plates
to GCB plates for the following day’s experiment. Overnight plate-grown gono-
cocci were suspended in GCB to an optical density at 600 nm (OD600) of 0.1.
Then, 50 l of the cell suspension was mixed with 5 ml of liquid GCB agar, and
the mixture was poured over a plate containing 15 ml of solidified GC agar. Four
filter paper disks (6 mm in diameter; Schleicher & Schuell, Dassel, Germany)
were then placed on top of the solidified GCB agar-gonococci mix. The agents
tested on disks included AMP at 1 to 5 g per disk, CHL at 0.25 g per disk,
ERY at 0.1 to 0.5 g per disk, rifampin (RIF) at 0.05 to 0.5 g per disk and 2.5
to 10 l of Triton X-100 (TX-100) at 1:100 dilution.
Plating efficiency and determination of the MIC. The plating efficiency was
determined by plating dilutions of cell suspensions at an OD600 of 0.18 onto GCB
plates or Hb-Des plates. MICs were determined by plating diluted cell suspen-
sions on GCB plates containing doubling dilutions of antimicrobial agents; the
MIC was the lowest concentration that prevented growth.
RESULTS
Isolation of novel Hb mutants. We previously reported
spontaneously arising Hb-utilizing (Hb) colonies from hpuA
deletion mutants of FA1090, FA7167 (Hb, hpuA hpuB::cat)
and its derivative FA7186 (Hb, hpuA hpuB hmbR::) (6).
Some of them carried a point mutation in hpuB, whereas oth-
ers had mutations originally designated hpuA hgbX that
mapped outside the hpuAB locus (6). All of the hgbX mutants
grew well on Hb-Des plates and in liquid culture with Hb as the
sole source of iron (data not shown). The hgbX mutant strain
isolated from FA7167, FA7168, retained the cat cassette in
hpuB but became sensitive to CHL1. Nevertheless, it showed a
much smaller zone of growth inhibition, compared to wild-type
FA1090, when tested with disk loaded with CHL (Table 3).
Screening of its sensitivities to several other antimicrobial
agents revealed that FA7168 was also more sensitive to heme,
AMP, ERY, RIF, and TX-100 than FA7167 and FA1090 (Ta-
ble 3).
In liquid culture with Hb (1 M) as the sole source of iron,
the growth of FA7168 was inhibited by the addition of HSA
which binds free heme (16) (Fig. 1). This result is in contrast to
the behavior of FA1090, which is able to compete for heme
complexed to HSA by the expression of the HpuAB receptor
(6).
The Hb phenotype in FA7168 is due to a point mutation in
pilQ. Transformation of the Hb recipient FA7167 with pooled
plasmids containing chromosomal DNA from one hgbX mu-
tant, FA7168, resulted in isolation of a plasmid that contained
a point mutation in pilQ. Subsequent studies showed that this
point mutation was responsible for the growth on Hb in the
FIG. 1. Representative growth curves of the hpuA hpuB::cat pilQ1
point mutant, FA7168, and HpuAB phase on FA1090 in liquid cul-
tures, as measured by the OD600 in the Klett colorimeter. Gonococci
were grown in liquid cultures of CDM-Des supplemented with Hb (1
M) or Hb and HSA (16 M). Symbols: F, FA1090 in Hb; E, FA1090
in Hb-HSA; ■ , FA7168 in Hb; , FA7168 in Hb-HSA.



















FA1090 wild type, Hb 22 26 14 22 8 10 16 16
FA7167 (hpuA hpuB::cat), Hb 22 8 12 24 8 12 16 18
FA7168 (hpuA hpuB::cat pilQ1), Hb 28 16 26 36 22 10 14 16
a Values are diameters of the zone of growth inhibition around each 6-mm disk loaded with the indicated amount of antimicrobial agent measured after 24 h. Data
were from one representative experiment.
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absence of an Hb receptor and for increased sensitivity to
various antimicrobial agents. A T-to-G mutation occurred at
base 1761 of FA7168 pilQ coding sequence, resulting in an
F563L mutation in the predicted mature PilQ protein. Se-
quence from pilQ genomic PCR products from the other five
hgbX mutants—H1, H12, H15, H19, and H20—derived from
FA7186 (Hb hpuA hpuB hmbR::) revealed precisely the
same point mutation in one, i.e., FA7186H19. The other four
hgbX mutants had the wild-type pilQ sequence. Like FA7168,
FA7186H19 showed elevated sensitivities to various antimicro-
bial agents (data not shown). Therefore, the same F563L mu-
tation was independently isolated in two strain backgrounds
and designated pilQ1.
Moving FA7168 and FA7186H19 back into FA7167 back-
ground generated the Hb transformants FA7317, FA7294,
and FA7318 (all hpuA hpuB::cat pilQ1), supporting the no-
tion that their growth on Hb was dependent on preservation of
the pilQ1 point mutation. The necessity of PilQ for Hb utili-
zation in the hpuA pilQ1 mutants was also confirmed by the
insertional inactivation of pilQ. The pilQ:: transformants of
FA7294 and FA7317 were both completely unable to utilize
Hb for growth. As a control, a pilQ:: mutant of FA1090 Hb
still grew well on Hb-Des plates, as expected, because of the
presence of the HpuAB receptor in FA1090 (data not shown).
The Hb phenotype is independent of TonB and PilQ1 is
not an Hb receptor. The HpuAB and HmbR Hb receptors, as
well as the transferrin and the lactoferrin receptors, are de-
pendent on TonB for function. To test for possible TonB
dependence of the Hb supported growth of pilQ1 mutant,
FA7317 tonB were insertionally inactivated with the  cassette.
Although the previously obtained hpuA hpuB point mutants
still required TonB to utilize Hb as the sole source of iron (6),
the pilQ1 tonB double mutants grew on iron-chelated medium
containing Hb but not transferrin (data not shown). Thus, the
Hb phenotype conferred by pilQ1 was independent of TonB.
The possibility that the pilQ1 mutation might restore Hb
receptor activity to strains carrying mutations in hpuAB was
examined by radioimmunoassay. FA7168 exhibited no iron-
dependent binding of Hb and very low levels of Hb binding
compared to HpuAB phase on FA1090 that expressed a wild-
type form of the HpuAB Hb receptor (Table 4). The Hb
binding was also low in parent FA7167 (hpuA hpuB::cat
pilQ) (Table 4). The minor differences between FA7167 and
FA7168 were not significant (Student t test).
Different classes of hpuA hgbX mutants. Compared to their
immediate parents, FA7167 and FA7186, the hgbX mutants
were more sensitive to the same set of antimicrobial com-
pounds and protoporphyrin IX (PPIX) and FePPIX. However,
among six mutants identified, the two that were subsequently
determined to be pilQ mutants, FA7168 and FA7186H19, were
relatively less sensitive to TX-100, PPIX, and FePPIX but
more sensitive to the antibiotics RIF and ERY (data not
shown). The MIC of PPIX was 250 g/ml for FA1090 com-
pared to 	4 g/ml for FA7168 and FA7186H19 and 
2 g/ml
for the other hgbX mutants. These phenotypic differences sug-
gested that there might be different genotypic classes of hgbX
mutants with a similar Hb phenotype.
According to Drake et al. (14), PilP, a pilus biogenesis li-
poprotein, affects the expression of PilQ as a macromolecular
multimer. To check for the possibility that a mutation in pilP
resulted in the Hb phenotype of other hgbX mutants,
genomic PCR products of the pilP gene of all hgbX mutants
were sequenced. Their sequences were the same as wild-type
FA1090. The increased sensitivity to TX-100 and RIF of the
hgbX mutants prompted an attempt to determine whether the
mtr CDE-encoded efflux pump might be involved (17). Intro-
duction of mtrC::Km, mtrD::Km, and mtrE::Km mutations (38)
by transformation into Hb strain FA7167 (hpuA hpuB::cat)
resulted in increased sensitivity to TX-100 and RIF as expected
but none of the insertional mutants acquired the ability to grow
on Hb-Des plates (data not shown). Thus, it seemed unlikely
that the mtr genes were involved in the mutations that resulted
in ability to grow on Hb in the absence of a Hb receptor. The
possible involvement of another efflux pump, NorM (33), that
recognizes cationic antimicrobial agents was also studied. Se-
quencing the gene norM also revealed no difference between
the hgbX mutants and the wild type. At present, the identities
of the other hgbX mutations are unknown.
Increased entry of free heme due to pilQ1. When 5 g of
heme was placed in a well cut into a GCB-Des agar plate
previously spread with wild-type strain FA1090 (data not
shown) or hpuA hpuB::cat strain FA7167, these strains exhib-
ited a ring of dense growth surrounding an inner zone of
growth inhibition (Fig. 2). In contrast, the pilQ1 mutants ex-
hibited a thin ring of growth with a larger inner zone of growth
inhibition (Fig. 2), indicating increased sensitivity to heme
toxicity in pilQ1 mutants. This result is consistent with these
mutants’ increased sensitivity to antibiotics and the porphyrins
PPIX and FePPIX (40) (Table 3 and data not shown). With
reduced amount of heme (2.5 g) in the central wells, zones of
growth inhibition decreased in both the pilQ and the pilQ1
strains (Fig. 2). The dose dependence of zone of growth inhi-
bition confirmed that excess free heme was the cause of growth
inhibition and that the entry of free heme was augmented in
pilQ1 mutants.
The increased sensitivity to porphyrins of strains with the
pilQ1 point mutation strongly suggested that entry of intact
porphyrins was increased in the mutant background. To fur-
ther address the question of whether the pilQ1 mutation re-
sulted in entry of heme or merely iron released from heme into
the cell, hemA mutants were constructed in the relevant
strains. Mutation in hemA of FA1090 results in inability to
grow without exogenous heme source, since the hemA mutants
are unable to synthesize their own heme (48). The hemA::
transformant, FA7322, of FA7317 (Hb, pilQ1) grew well on






FA1090 (HpuAB phase on) Hb Iron replete 0.24  0.03
Iron limited 1.51  0.36
FA7167 (hpuA hpuB::cat) Hb Iron replete 0.07  0.02
Iron limited 0.05  0.03
FA7168 (hpuA hpuB::cat pilQ1) Hb Iron replete 0.08  0.04
Iron limited 0.08  0.05
a 125I-labeled anti-human Hb antibody bound to gonococcal bound Hb is
expressed as a percentage of the total counts per minute added to each well. Data
are averages of two experiments, each done in quadruplicate.
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Hb (data not shown), indicating that heme, or at least an intact
porphyrin ring, entered the pilQ1 mutant cells.
Additional evidence for the role of PilQ in the entry of free
heme and antimicrobial compounds was provided by analysis
of the effects of pilQ inactivation on both the pilQ and the
pilQ1 strains. Inactivation of PilQ completely prevented the
zone of heme toxicity in both FA7319 (FA7167 pilQ::) and
FA7320 (FA7317 pilQ1::) (Fig. 2). Reversal of hypersensitiv-
ities to AMP, ERY, RIF, and TX-100 was also obvious in
FA7320 compared to the parent pilQ1 mutant (Fig. 3). Slight
decrease of sensitivities to ERY, RIF, and TX-100 was also
observed in the pilQ:: mutant of FA1090, FA7311 (Table 5).
Moreover, introduction of pilQ1 by transformation of RM11.2
recA6 (25) (FA7339) resulted in hypersensitivity to the same
agents (data not shown), showing that the effects of pilQ1 were
not dependent on a mutation in the HpuAB receptor. We
concluded that PilQ forms an entry channel for free heme and
certain other antimicrobial compounds in wild-type gonococci,
which is accentuated by the pilQ1 point mutation. Since there
still was growth around wells containing free heme in FA1090
and FA7167 derivatives lacking PilQ, there also must be addi-
tional routes for entry of heme that do not depend on PilQ.
The pilQ1 mutation decreases pilus expression and trans-
formation efficiency. The product of pilQ is essential for the
biogenesis of type IV pili in Neisseria gonorrhoeae (13). To
ascertain the role of the PilQ point mutation in pilus assembly
and function, the hpuA hpuB::cat pilQ1 mutation was trans-
formed into RM11.2recA6, a defined pilin variant of strain
FA1090 with a regulatable recA that allows for IPTG control of
DNA transformation and pilin antigenic variation (34). All
RM11.2recA6 derivatives were shown to carry identical pilE
sequences, ensuring that differences in piliation were not due
to changes in pilus expression due to pilin variation (data not
shown). To directly examine piliation of the RM11.2recA6
hpuA hpuB::cat and RM11.2recA6 hpuA hpuB::cat pilQ1
transformants, FA7332 and FA7333, immunogold electron mi-
croscopy with an anti-pilin peptide antibody was performed.
Compared to the wild-type RM11.2recA6, the number of cells
expressing pili was unchanged in FA7332 but was reduced by
	2-fold in the pilQ1 mutant FA7333 (Fig. 4), which neverthe-
less retained a piliated colony morphology. The pilQ1 mutant
also showed sevenfold-lower transformation efficiency than
FA7332 (Fig. 4), although there is still substantial transforma-
tion competence at 103 transformants/CFU.
To determine the effects of pilus expression on the entry of
antimicrobial compounds through PilQ macromolecular com-
plex, pilE mutants were made from FA7332 and FA7333 and
compared to RM11.2recA6 pilE (FA7336). The transforma-
tion efficiencies for each of the three pilE mutants were
similar and reduced ca. 5 to 6 logs compared to the isogenic
Pil strains (data not shown). Loss of pilus expression in pilQ1
mutant had little effect on Hb-supported growth, but the pilE
pilQ1 double mutant, FA7338, showed increased sensitivity to
heme toxicity (Fig. 5) and slightly increased sensitivity to AMP
and TX-100 (Table 6). Thus, pilus expression might compete
with certain molecules for the PilQ macromolecular complex.
PilT is essential for the observed phenotypic effects of the
pilQ1 mutation. The pilus accessory gene pilT plays a crucial
role in twitching motility and pilus retraction (27, 30), acting as
a conditional antagonist of stable pilus fiber formation (50, 51,
52). In order to examine the influence of PilT in a pilQ1
background, we introduced two kinds of pilT loss-of-function
mutations into pilQ wild-type strains FA1090, FA7167, and
pilQ1 mutants FA7168, FA7186H19, FA7317, and FA7318,
some with pilT::erm and the others with pilT::tet. The pilQ1
pilT::erm double mutants showed low plating efficiencies on
Hb-Des plates (ca. 5  103 Hb-Des CFU/GCB CFU). After
48 h of incubation on Hb-Des plates, they exhibited a mixture
of a few regular-sized and many tiny colonies. Passage of the
regular sized colonies to fresh Hb-Des plates yielded uniformly
regular-sized colonies. Passage of tiny colonies on the same
media continued to yield the same proportions of tiny and
normal-sized colonies. The rates of colony variation suggested
possible phase variation of another surface component, but no
differences were found in PilC expression (determined by
Western blots with anti-PilC polyclonal sera; data not shown).
Similar low plating efficiencies and apparent phase variation
FIG. 2. Free heme supported growth of hpuAB mutants and their
pilQ inactivation mutants. GCB-Des plates were spread with cell sus-
pensions of respective strains: FA7167, hpuA hpuB::cat pilQ parent;
FA7319, pilQ:: transformant of FA7167; FA7317, pilQ1 transformant
of FA7167; FA7320, pilQ1:: transformant of FA7317. Wells were cut
into the agar and loaded with 50 l of heme at 0.1 or 0.05 g/l.
Images were obtained after 48 h of incubation. At 5.0 g of heme per
well, FA7167 grew in a wide growth ring, whereas the pilQ1 mutant,
FA7317, showed a thin growth ring with a wide zone of growth inhi-
bition. Decreasing the amount of heme decreased the growth inhibi-
tion zones. Insertional inactivation of pilQ abolished heme toxicity.
FIG. 3. Effects of pilQ inactivation on pilQ1 mutant’s sensitivity to
antimicrobial agents. Filter paper disks placed on the surface of
FA7168 (hpuA hpuB::cat pilQ1)- and FA7320 (hpuA hpuB::cat
pilQ1::)-coated plates were loaded with AMP (1 g per disk, top
left), ERY (0.25 g, top right), RIF (0.05 g, bottom left), and TX-100
(5 l of a 1:100 dilution, bottom right). Images were obtained after
24 h of incubation.
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from tiny colonies to large normally growing colonies were
noted in earlier studies of double mutants that expressed nei-
ther PilQ nor PilT, which was shown to be the result of toxicity
from assembled intracellular pilus fibers that could neither be
extruded through PilQ, nor broken down due to loss of PilT
function (52). In that case, the large-colony variants were due
to pilin mutations that resulted in the inability to assemble
toxic fibers. To further address whether a similar phenomenon
in the pilQ1 pilT::erm double mutants might account for low
plating efficiencies and frequent reversion to large-colony vari-
ants on Hb-Des plates, the pilQ1 pilT::erm mutations were
introduced into FA7332 (RM11.2recA6 hpuA hpuB::cat),
which does not undergo pilin variations due to the recA6 mu-
tation in the absence of induction of expression of recA func-
tion by IPTG (36). The results showed that there were similar
low plating efficiencies on Hb-Des plates and the appearance
of large and small colony variants on these plates (data not
shown). This strongly suggested that recombination pathways
were not necessary to the reversions to normal growth and
therefore that pilin variations were not responsible for the
restored growth.
Loss of PilT expression decreased the sensitivity of pilQ1
mutants to heme toxicity. The pilQ1 pilT::erm double mutant,
FA7340 (in RM11.2recA6 hpuA hpuB::cat background), ex-
hibited a heavier ring of growth and a smaller inner zone of
growth inhibition around the central well containing heme,
compared to the parent strain with intact PilT function (Fig. 5).
FA7340 was less sensitive to AMP, RIF, and TX-100 than its
parent, FA7333 (Table 6), whereas the pilT::tet mutant of
FA7186H19 (hpuA hpuB::cat pilQ1), FA7350, demonstrated
decreased sensitivity to ERY (data not shown). Loss of PilT
also reduced the entry of some antimicrobial compounds in
pilQ wild-type strains. Although the effect of pilT inactivation
in FA1090 was small, differences were significant for sensitiv-
ities to ERY, RIF, and TX-100 (Table 5). Thus, PilT was
required for the susceptibility to antibiotics, detergents, and
heme/porphyrins that can utilize both wild-type and PilQ1
macromolecular complex for entry into the bacterial cell.
DISCUSSION
We initiated this study to elucidate the mechanisms respon-
sible for receptor-independent uptake of iron and heme from
Hb, based on the previous isolation of gonococcal mutants that
were able to grow on Hb despite mutational loss of HpuA, the
lipoprotein coreceptor that normally is essential for the func-
tion of the HpuAB receptor (6). The hgbX mutants fell into
two general classes based on differences in their susceptibilities
to a variety of antimicrobial agents. Although all were more
susceptible to generally hydrophobic antibiotics and TX-100
than the wild type, some were particularly susceptible. One of
the two classes of mutants turned out to have a point mutation
FIG. 4. Bar graph illustrating transformation efficiencies (A) and electron micrographs comparing the piliation (B) of RM11.2recA6 (wild type),
FA7332 (hpuA hpuB::cat), and FA7333 (hpuA hpuB::cat pilQ1). The piliation of these three strains is given as the percentage of cells expressing
pili, as visualized by immunogold electron microscopy with anti-pilin sera, and the percent piliation is indicated on each electron micrograph. The
bar in each electron micrograph is 500 nm. Two grids for each strain were examined. The numbers of cells examined were 216, 346, and 558,
respectively. All three strains exhibited predominantly bundled pili. FA7333 showed decreased piliation as well as decreased transformation
efficiency. The asterisk in panel A indicates a significant difference by using the Student t test (P 
 0.05) compared to RM11.2 recA6 and FA7332.
TABLE 5. Insertional inactivation of pilQ and pilT in FA1090 decreased sensitivities to ERY, RIF, and TX-100
Straina
Mean zone of growth inhibition (mm)b  SD with:
AMP (2 g) ERY (0.5 g) RIF (0.1 g) TX-100(10 l of a 1:100 dilution)
FA1090 P, Hb 17.6  1.1 19.8  3.5 18.0  1.0 11.0  1.0
FA1090 P, Hb 18.2  1.5 20.2  3.3 18.4  1.5 11.0  1.6
FA7311 (FA1090 pilQ::), Hb 18.0  1.1 18.8  4.3* 16.0  2.1* 9.3  1.0**
FA7348 (FA1090 pilT::tet), Hb 18.3  1.5 18.7  3.0* 16.2  1.0* 9.5  0.8*
a For FA1090, phenotypically piliated (P) and nonpiliated (P) colonies were selectively passed in preparation for the following day’s experiment.
b Each value is an average of five zones of growth inhibition obtained with the indicated amount of antimicrobial agent measured from five experiments after 48 h
of incubation. A paired t test showed significant differences (*, P 
 0.05; **, P 
 0.01) as indicated compared to FA1090 P.
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near the 3 end of pilQ (pilQ1), whereas the other was normal
in all tested genes. Efforts to clone the gene(s) responsible for
the remaining uncharacterized hgbX mutants other than pilQ
by the same strategy used to isolate the pilQ1 mutation have
been unsuccessful. The results described in this communica-
tion showed that the Hb phenotype of the pilQ1 mutants was
neither dependent on HpuAB or TonB nor on Hb binding to
whole cells. Rather, growth on Hb was due to the release of
free heme from Hb and entry through a channel or channels
that did not depend on the Hb receptor. We presume that
heme was released from Hb on the cell surface or in the
extracellular medium because HSA prevented the entry of
heme. So far, there has not been any report of Hb entry in any
bacterial species. The relatively large sizes of albumin and Hb
(molecular weights of ca. 69,000 and 64,500, respectively) and
the funnel-shaped cavity in the PilQ macromolecule (9) make
it unlikely that either could enter through the PilQ channel.
Demonstration that the pilQ1 mutation resulted in increased
entry of heme, TX-100, and a variety of antibiotics was sur-
prising, since PilQ is not known to facilitate the entry of exog-
enous compounds. It is likely that only a few mutations in pilQ
result in this phenotype, since the same F563L mutation was
isolated independently twice. Very recently, an additional and
different pilQ mutation has been isolated that results in in-
creased resistance to antibiotics, further suggesting that wild-
type PilQ allows the entry of a variety of compounds (R.
Nicholas et al., unpublished data). Our demonstration that the
phenotype was very closely linked to pilQ1 and was lost by
insertional inactivation of pilQ1 suggests that the effects were
mediated by changes within PilQ. We cannot absolutely ex-
clude the possibility that the PilQ F563L mutation provides
these phenotypes by affecting membrane integrity or another
secondary effect. The simplest hypothesis is that PilQ can di-
rectly allow entry of these molecules into the bacterial cell and
that the F563L mutation increases the number of molecules
that can efficiently utilize this route.
The conclusion that PilQ forms not only a pore for exit of
the assembled pilus fibril (13, 52) but also a channel for entry
of heme and various antimicrobial agents is strengthened by
the additional observation that loss of pilT function decreased
the effects of the pilQ1 mutation. PilT is responsible for twitch-
ing motility mediated by retraction of the pilus fibril (27, 30). It
also is necessary for degradation of the pilus fibril when PilQ is
not available for export of the intracellular assembled pilus
fibril; in the absence of both PilQ and PilT, cell viability is lost
unless other secondary mutations in pilE prevent formation of
what would otherwise be toxic intracellular pilus fibrils (52).
PilT is also required for the transport of DNA into the cell for
genetic transformation (48). Our observation that inactivation
of pilT in strains carrying the pilQ1 missense mutation resulted
in decreased sensitivity to heme, TX-100, and antibiotics ar-
gues that PilT normally increases the entry properties of the
PilQ macromolecular complex. Perhaps the PilQ-dependent
entry of small molecules shares mechanistic properties with
pilus retraction, where the assembled pilus is imported back
into the cell. It is not clear whether heme and antimicrobial
agents bind to pili or to PilQ, but modestly increased sensitivity
to heme and certain antimicrobial agents in a pilE construct
(Fig. 5 and Table 6) suggests that either extruded pili compete
with exogenous compounds for PilQ or pili partially impeded
passage of these compounds through the PilQ channels.
Many bacteria possess receptors for binding and utilizing
heme-carrying compounds (43). The entrance of heme in
gonococci is known to be TonB independent (3, 7, 44, 48), and
no clear evidence for a heme receptor in the pathogenic Neis-
seria spp. has been produced. Our results demonstrated that
some heme enters through a PilT- and PilQ-dependent path-
way, but there almost certainly must be an additional mecha-
nism for heme entry as well, since strains lacking both an Hb
receptor and PilQ were able to grow on free heme (Fig. 2). It
FIG. 5. Effects of pilE deletion and pilT inactivation on Hb (50 l
at 10 g/l) and heme (50 l at 0.1 g/l) supported growth of a pilQ1
mutant, FA7333 (hpuA hpuB::cat pilQ1, Hb). FA7338 is the pilE
transformant and FA7340 is the pilT::erm transformant of FA7333.
Images were obtained after 48 h of incubation. The pilQ1 pilT double
mutant gave only isolated large colonies around the Hb well. The zone
of growth inhibition around the heme well was wider in the pilQ1 pilE
double mutant but was reduced in the pilQ1 pilT double mutant com-
pared to that of FA7333.
TABLE 6. Deletion of pilE and inactivation of pilT changed sensitivities to TX-100 and certain antibiotics in pilQ1 mutants
Strain
Mean zone of growth inhibition (mm)a  SD with:
AMP (1 g) ERY (0.1 g) RIF (0.05 g) TX-100(5 l of a 1:100 dilution)
FA7332 (RM11.2recA6 hpuAB), Hb 16.3  2.9** 7.7  3.3** 14.3  2.3** 7.0  2.4**
FA7333 (pilQ1 mutant of FA7332), Hb 22.2  1.9 19.5  3.3 30.0  2.3 16.2  2.9
FA7338 (FA7333 pilE) 23.7  1.8* 19.1  2.8 30.0  1.8 20.6  1.2*
FA7340 (FA7333 pilT::erm) 21.3  1.8* NA 23.4  2.8** 7.4  2.3**
a Each value is an average five zones of growth inhibition obtained with the indicated amount of antimicrobial agent measured from five experiments after 48 h of
incubation. NA, not applicable. A paired t test showed a significant difference (*, P 
 0.05; **, P 
 0.01) as indicated compared to FA7333.
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was curious that there was no toxicity when Hb was the source
of heme, as opposed to adding free heme to the media. This
may reflect relatively low concentrations of free heme released
by Hb, compared to the amounts added to the wells in the
assays used. Heme is known to be toxic for bacteria when in
excess (40). Indeed, use of iron regulated receptors for obtain-
ing heme from Hb under physiological circumstances may help
to control the amount of heme that enters the cell, thereby
avoiding toxicity.
Recent structural studies have utilized electron microscopy
to establish proposed quaternary structures for members of the
secretin family. According to Collins et al. (8, 9), the assembled
meningococcal PilQ product takes the form of a doughnut
composed of 12 identical subunits, surrounding a central cav-
ity. When viewed from the side, the assembly is proposed to
have a rounded, conical profile. Viewed from the top, the open
end of the central channel apparently is just large enough to
accommodate the pilus fibril, and the tapered end presumably
blocks the channel (9). How the PilQ macromolecular assem-
bly might be gated open so as to allow exit of pilus fibrils has
been the subject of speculation involving the propulsive force
of the pilus, which is sufficient to cause membrane protrusions
in cells lacking PilQ and PilT (52). Such a mechanism might
account for the specificity of the channel for pili. The only
other function associated with the pilus-PilQ channel has been
uptake of transforming DNA, which depends on pili, PilC,
PilT, and other members of the complex (51). How DNA
enters through this channel remains unclear; however, our data
suggest that pilQ1 changes the specificity of the channel to
allow increased entry of other molecules into the cell.
Studies on certain other members of the secretin family (34)
have demonstrated gated channel properties. The pIV secretin
for the filamentous phage f1 forms an ion conductive pore in
planar lipid bilayers, and mutant forms of the protein allow
import of molecules in whole cells to which E. coli normally is
resistant (28). Entry through the pIV channel was decreased by
production of phage that could not be released from the cell
surface (29). The Klebsiella oxytoca secretin PulD also forms
ion conductive channels in planar lipid bilayers (31). Each of
these secretins has a quaternary shape similar to that proposed
for PilQ (8). Future studies on PilQ might be expected to show
voltage-dependent ion conductive channels in planar lipid bi-
layers, and mutants of PilQ such as the one we describe should
alter the properties of the channel. These mutants hopefully
also will help us to understand how PilQ interacts with other
members of the complex (PilT, PilP, and PilC) in the secretion
of pili and the mechanisms and physiological roles for entry of
exogenous compounds, including heme and antibiotics through
PilQ.
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